Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.67 |
| ▸ | THRA | P10827 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.62 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | PTPRB | P23467 | 1/20 | 0.57 |
| ▸ | CDC25A | P30304 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.57 |
| ▸ | PTEN | P60484 | 1/20 | 0.57 |
| ▸ | PTPMT1 | Q8WUK0 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.55 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.51 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL9871069 | 0.95 | FFAR4 (0.62) | FFAR4THRATHRBFFAR1KEAP1 | |
| SCHEMBL13525204 | 0.90 | FFAR1 (0.71) | FFAR4THRATHRBFFAR1KEAP1 | |
| SCHEMBL5101251 | 0.89 | HDAC3 (0.63) | FFAR4THRATHRBFFAR1TAAR1 | |
| SCHEMBL3249491 | 0.87 | MAPT (0.62) | FFAR4THRATHRBFFAR1 | |
| SCHEMBL7337631 | 0.86 | TAAR1 (0.57) | FFAR4THRATHRBFFAR1TAAR1 | |
| Phenyl Propionic Acid SCHEMBL28551157 | 0.86 | FFAR4 (0.57) | FFAR4THRATHRBFFAR1KEAP1 | |
| SCHEMBL29057552 | 0.86 | MAPT (0.66) | FFAR4 | |
| SCHEMBL9663089 | 0.86 | MAPT (0.66) | FFAR4 | |
| SCHEMBL7507667 | 0.86 | MMP12 (0.54) | FFAR4THRATHRBFFAR1TAAR1 | |
| SCHEMBL765851 | 0.86 | MAPT (0.66) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-05-20 | — | — | US | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20220194909-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11B-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2022-06-23 | — | — | US | claimed |
| CN-110167933-B | As αVAzole amides and amines as integrin inhibitors | 百时美施贵宝公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2020210922-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11Β-HSD1) | PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE (CL) | 2020-10-22 | — | — | WO | claimed |
| US-7951765-B2 | Photoresist stripper composition for semiconductor manufacturing | TECHNO SEMICHEM CO., LTD. (KR) | 2011-05-31 | — | — | US | claimed |
| EP-1913448-B1 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | TECHNO SEMICHEM CO LTD (KR) | 2010-10-13 | — | — | EP | claimed |
| US-20090312216-A1 | Photoresist Stripper Composition for Semiconductor Manufacturing | TECHNO SEMICHEM CO., LTD. (KR) | 2009-12-17 | — | — | US | claimed |
| EP-1913448-A4 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | TECHNO SEMICHEM CO LTD (KR) | 2008-11-05 | — | — | EP | claimed |
| EP-1913448-A1 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | Techno Semichem Co., Ltd. (KR) | 2008-04-23 | — | — | EP | claimed |
| WO-2007021085-A1 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | TECHNO SEMICHEM CO., LTD. (KR) | 2007-02-22 | — | — | WO | claimed |
| WO-1996027369-A9 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | — | 1996-12-27 | — | — | WO | claimed |
| US-20260049060-A1 | TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS | NATIONAL HEALTH RES INST (TW) | 2026-02-19 | — | — | US | disclosed |
| US-12428403-B2 | N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-09-30 | — | — | US | disclosed |
| US-12404265-B2 | Substituted pyridine derivatives as SARM1 inhibitors | NURA BIO, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-05-20 | — | — | US | disclosed |
| EP-0393668-B1 | Method of preparation of benzaldehyde dialkyl acetals and new benzaldehyde dialkyl acetals | BASF AG (DE) | 1994-02-02 | — | — | EP | disclosed |
| US-5276049-A | Treatment of thrombosis | DR. KARL THOMAE GMBH (DE) | 1994-01-04 | — | — | US | disclosed |
| EP-0503548-A1 | Cyclic urea derivatives, medicaments contaning them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1992-09-16 | — | — | EP | disclosed |
| EP-0393668-A2 | Method of preparation of benzaldehyde dialkyl acetals and new benzaldehyde dialkyl acetals | BASF Aktiengesellschaft (DE) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404265-B2 | Substituted pyridine derivatives as SARM1 inhibitors | SARM1, SARNP, ADRM1 | FFAR4 4580/4885THRA 4180/4885THRB 3382/4885 |
| US-20260049060-A1 | TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS | OPRK1, OPRD1, OPRM1 | FFAR4 882/4885THRA 99/4885THRB 77/4885 |
| US-12428403-B2 | N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists | SSTR4, SSTR3, SSTR1 | FFAR4 98/4885THRA 281/4885THRB 314/4885 |
| US-20220194909-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11B-HSD1) | HSD11B1, HSD11B2, CYP11B1 | FFAR4 1638/4885THRA 3054/4885THRB 1918/4885 |
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | HSD11B1, HSD11B2, HSD17B1 | FFAR4 1493/4885THRA 2803/4885THRB 1973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.